The Dangers, Cost of Weight Loss Drugs — How to Avoid a Life Sentence

Beyond being a major public health challenge, obesity carries extreme implications for employers and their teams. In fact, a recent report estimates obesity cost U.S. employers and employees $425.5B in 2023. The study found that of the 158 million employees working in the private and government sectors, 30% were classified as obese, and 34% were overweight.

In this article for The Self-Insurer, Jakki Lynch, Carbon Stop Loss Solutions’ Director of Cost Containment, explains, “The direct costs of obesity are healthcare expenditures for medical treatment, preventative services, diagnostic testing, bariatric surgeries, and medications. While the newly approved drugs for weight management have recently gained considerable attention, they do not come without considerations for cost and health complications.”

Read the full article here.